Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 4/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.42 |
| ▸ | PDK3 | Q15120 | 4/20 | 0.42 |
| ▸ | PDK4 | Q16654 | 4/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.38 |
| ▸ | EEF2K | O00418 | 1/20 | 0.38 |
| ▸ | PLK4 | O00444 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5151209 | 0.87 | TRPV1 (0.42) | SMN1; SMN2LMNAMAPK1RXFP1NPC1 | |
| SCHEMBL5151216 | 0.86 | RXFP1 (0.38) | SMN1; SMN2PDK1PDK2PDK3PDK4 | |
| SCHEMBL6242304 | 0.86 | KMT2A (0.47) | SMN1; SMN2LMNAALDH1A1MAPTALOX12 | |
| SCHEMBL5155513 | 0.83 | SMN1; SMN2 (0.39) | SMN1; SMN2LMNAALDH1A1MAPTALOX12 | |
| SCHEMBL5155508 | 0.83 | SMN1; SMN2 (0.39) | SMN1; SMN2LMNAALDH1A1MAPTALOX12 | |
| SCHEMBL12387210 | 0.83 | PDK1 (0.55) | SMN1; SMN2ALDH1A1MAPTPDK1PDK2 | |
| SCHEMBL5731619 | 0.83 | POLB (0.54) | SMN1; SMN2ALDH1A1MAPTHPGDMAPK1 | |
| SCHEMBL5151689 | 0.82 | ALDH1A1 (0.44) | SMN1; SMN2LMNAALDH1A1MAPTALOX12 | |
| SCHEMBL6237368 | 0.82 | CYP1A2 (0.41) | SMN1; SMN2LMNAALDH1A1MAPTALOX12 | |
| SCHEMBL29803307 | 0.82 | RXFP1 (0.55) | SMN1; SMN2LMNAMAPTRXFP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | SMN1; SMN2 2170/4885LMNA 1667/4885ALDH1A1 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.